To assess the effects of APOE ε4 on synaptic changes at different amyloid-seeding stages in AD iNs, we examined the expression of a presynaptic marker, VGLUT1, and a postsynaptic marker, Synapsin1, in the APOE ε4-expressing AD patient iNs. This evidence concerns the gene APOE and Alzheimer disease.